ROXADUSTAT for Nephrogenic anaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 57 adverse event reports in the FDA FAERS database where ROXADUSTAT was used for Nephrogenic anaemia.
Most Reported Side Effects for ROXADUSTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 14 | 14.0% | 6 | 5 |
| Gastrointestinal haemorrhage | 9 | 9.0% | 0 | 9 |
| Haemoglobin increased | 9 | 9.0% | 1 | 0 |
| Renal impairment | 9 | 9.0% | 0 | 1 |
| Hyperkalaemia | 8 | 8.0% | 1 | 2 |
| Product use issue | 7 | 7.0% | 3 | 2 |
| Shunt occlusion | 7 | 7.0% | 1 | 3 |
| Bronchopulmonary aspergillosis | 5 | 5.0% | 0 | 5 |
| Central hypothyroidism | 5 | 5.0% | 0 | 3 |
| Diarrhoea | 5 | 5.0% | 1 | 1 |
| Hypertension | 5 | 5.0% | 0 | 1 |
| Influenza | 5 | 5.0% | 0 | 5 |
| Nausea | 5 | 5.0% | 2 | 0 |
| Pancytopenia | 5 | 5.0% | 0 | 5 |
Other Indications for ROXADUSTAT
Other Drugs Used for Nephrogenic anaemia
DARBEPOETIN ALFA (5,332)
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331)
ARANESP (1,740)
DAPRODUSTAT (859)
ERYTHROPOIETIN (750)
PEGZEREPOETIN ALFA (325)
EPOETIN ALFA-EPBX (169)
VADADUSTAT (140)
MIRCERA (100)
ENARODUSTAT (66)